Patients with diabetes have alternatives to rosiglitazone
Links shared publicly online about this topic.
- 1,003total visits
Patients with diabetes have alternatives to rosiglitazone
View full resource at theheart.org
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, FDA, Avandia, Avandamet, Avandaryl
Most Recently Shared on July 22, 2010 at 8:46 pm By:
Patients with diabetes have alternatives to rosiglitazone, experts say: Following the recent controversial FDA adv... http://bit.ly/bokb3A
Resveratrol inhibits cellular oxidative stress in monocytes cultured from type 1 diabetic patients | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.” View full resource at greenmedinfo.com
Most Recently Shared on August 5, 2011 at 6:48 pm By:
A low carbohydrate diet has the potential to reduce abdominal fat and adverse lipid changes in patients with type 2 diabetes. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes.” View full resource at greenmedinfo.com
Most Recently Shared on July 26, 2011 at 10:02 am By:
Black cumin seeds have significant anti-diabetic effects in type 2 diabetics. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus.” View full resource at greenmedinfo.com
Most Recently Shared on July 5, 2011 at 10:42 pm By:
Heart risks of diabetes drugs compared | NHS Choices | Nursing Times
nursingtimes.net — “BBC News reports that researchers have said that --a drug to treat diabetes, Actos, would be a --'sensible alternative--™ to one which was banned last year--. The BBC said that Avandia, also known as rosiglitazone, was suspended in Europe but is still available in the US and Canada.” View full resource at nursingtimes.net
Most Recently Shared on March 27, 2011 at 12:48 am By:
Behind the Headlines Heart risks of diabetes drugs compared: BBC News reports that researchers have said that “a... http://bit.ly/gl3kef
Study May Lead To Less Frequent Diabetes Insulin Treatments
medicalnewstoday.com — “A new study shows that an alternate form of insulin may be approved in upcoming years that is longer lasting, overall helping patients living with diabetes to have an improved quality of life by n” View full resource at medicalnewstoday.com
Most Recently Shared on March 10, 2011 at 6:05 pm By:
Study May Lead To Less Frequent Diabetes Insulin Treatments http://mnt.to/3S8X #healthnews
Competing risks analysis highlights new targets in preventing ESRD and death of diabetics - QualityPoint Technologies
qualitypointtech.net — “(University of Helsinki) Many patients with Type 1 diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome. Now, the researchers have determined the major predictors of the cumulative incidence of ESRD and pre-ESRD mortality in patients with Type 1 diabetes and macroalbuminuria while incorporating the competing risk for the alternate outcome into a Fine-Gra” View full resource at qualitypointtech.net
Most Recently Shared on February 18, 2011 at 10:00 am By:
Competing risks analysis highlights new targets in preventing ESRD and death of diabetics: (University of Helsinki... http://bit.ly/e7fJNp
Medical News: New Avandia Label Spells Out Restrictions - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Obeying a 2010 FDA directive, the manufacturer of the star-crossed diabetes drug rosiglitazone (Avandia) has now finalized new label language -- restricting the drug's use to patients already taking i” View full resource at medpagetoday.com
Most Recently Shared on February 8, 2011 at 10:56 am By:
New Avandia Label Spells Out Rstrictions. Recommended 4 those that have failed othr antiglycemics & thos currently takn http://t.co/3tENlGR
Red Wine Rivals Diabetes Drug in Lab Tests | Health News | News & Features | Wine Spectator
winespectator.com — “Researchers working in biotechnology laboratories in Vienna have found that red wine contains favorable levels of a chemical currently used to treat type 2 diabetes patients. In time, they say, red wine treatments may offer an alternative to current therapies. In the most promising experiment, 100 milliliters of a 2003 Blaufrnkisch contained four times the recommended daily dose of rosiglitazone, a commercially available drug used to treat type 2 diabetes, manufactured by GlaxoSmithKline and mar” View full resource at winespectator.com
Most Recently Shared on February 2, 2011 at 2:27 pm By:
Ivan Oransky Health Communicator and Doctor
Does wine have Avandia's problems? RT @terroirNY: "100 ml 2003 Blaufränkisch contained 4x daily dose of rosiglitazone" http://cot.ag/hfRkBN
There are 17 randomized trials on statin treatment showing an increased incidence of diabetes. | GreenMedInfo | Toxic Article | Natural Medicine | Alternative Medicine
greenmedinfo.com — “This toxicological article on GreenMedInfo.com concerns - Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials.” View full resource at greenmedinfo.com
Most Recently Shared on December 29, 2010 at 8:58 pm By:
Sayer Ji CAM and Health Advocate
Increased diabetes risk is one of the 181 diseases associated with statin use we have uncovered, all of which can... http://fb.me/BftGYWTh
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.” View full resource at greenmedinfo.com
Most Recently Shared on July 20, 2010 at 6:35 pm By:
Sayer Ji CAM and Health Advocate
The controversy over Avandia (Rosiglitazone) continues. Soon after the FDA's expert panel voted in favor of... http://fb.me/DJ3ESAkh
Scientific Leaders Urge Type 2 Diabetes Patients To Remain On Their Prescribed Medications Unless Instructed Otherwise By Their Health Care Provider
medicalnewstoday.com — “Over the past several weeks reports have again surfaced regarding the cardiovascular safety of the diabetes drug rosiglitazone. While some analyses have suggested an increased cardiovascular risk” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2010 at 2:42 pm By:
MedicalNewsToday: Scientific Leaders Urge Type 2 Diabetes Patients To Remain On Their: http://bit.ly/afcd7A Full http://bit.ly/cEH4xj
Diabetes Type 2 Drug Avandia (Rosiglitazone) Linked To Higher Stroke, Heart Failure And Death Risk Compared To Actos (Pioglitazone)
medicalnewstoday.com — “Patients aged at least 65 years who have diabetes type 2 and take Avandia (Rosiglitazone) have a higher risk of developing stroke, heart failure, and even dying compared to similar patients who ta” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 4:40 pm By:
Diabetes Type 2 Drug Avandia (Rosiglitazone) Linked To Higher Stroke, Heart Failure And Death Risk Compared To Act... http://mnt.to/f/3Fwy
JAMA -- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone, June 28, 2010, Graham et al. 0 (2010): jama.2010.920v1
jama.ama-assn.org — “JAMA is a highly cited weekly medical journal that publishes peer-reviewed original medical research findings and editorial opinion” View full resource at jama.ama-assn.org
Most Recently Shared on June 28, 2010 at 3:31 pm By:
eyeonfda Pharma and Health Lawyer
The JAMA Study published today on Actos and Avandia and risk - the saga continues - http://ow.ly/24d8V
Medical News: Drug Combo May Prevent Diabetes - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “A low-dose combination of rosiglitazone (Avandia) and metformin appears to prevent type 2 diabetes in patients with impaired glucose tolerance, researchers have found.” View full resource at medpagetoday.com
Most Recently Shared on June 3, 2010 at 5:19 pm By:
Drug Combo May Prevent Diabetes (CME/CE): A low-dose combination of rosiglitazone (Avandia) and metformin appears ... http://bit.ly/bGpALB
Advertisement
